Aitana Giner-Juan

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Carbon emissions of a vaccine trial implemented in Uganda: retrospective assessment to identify actions to enhance researchers' environmental responsibilities.

Carbon emissions of a vaccine trial implemented in Uganda: retrospective assessment to identify actions to enhance researchers' environmental responsibilities.

Journal: BMJ open

Published: July 16, 2026

Approaches to ensure quality of information provision and consent processes for vaccine clinical trial participation in Sub-Saharan Africa: A scoping review.

Approaches to ensure quality of information provision and consent processes for vaccine clinical trial participation in Sub-Saharan Africa: A scoping review.

Journal: Clinical trials (London, England)

Published: June 27, 2025

Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.

Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.

Journal: Lancet (London, England)

Published: June 14, 2025

Low-Dose Yellow Fever Vaccine in Adults in Africa.

Low-Dose Yellow Fever Vaccine in Adults in Africa.

Journal: The New England journal of medicine

Published: February 19, 2025

Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines.

Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines.

Journal: The Lancet. Infectious diseases

Published: January 08, 2024

The life-long protective immunity of yellow fever vaccination: time to review?

The life-long protective immunity of yellow fever vaccination: time to review?

Journal: The Lancet. Global health

Published: December 08, 2023

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Journal: The Lancet. Infectious diseases

Published: November 07, 2022

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Journal: The Lancet. Infectious diseases

Published: November 07, 2022

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.

Journal: Lancet (London, England)

Published: August 25, 2020

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.

Journal: Vaccine

Published: February 09, 2020

Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions.

Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions.

Journal: Vaccine

Published: September 05, 2019

Characteristics of human encounters and social mixing patterns relevant to infectious diseases spread by close contact: a survey in Southwest Uganda.

Characteristics of human encounters and social mixing patterns relevant to infectious diseases spread by close contact: a survey in Southwest Uganda.

Journal: BMC infectious diseases

Published: August 03, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026